arimoclomol

	arimoclomol
Trade Name
Orphan Indication	Inclusion Body Myositis
USA Market Approval	USA
USA Designation Date	2017-11-02 00:00:00
Sponsor	Orphazyme ApS;Ole Maaloes Vej 3, 2200 Copenhagen;